Bilateral Cataract after Taking Oxcarbazepine
Journal of the Korean Ophthalmological Society
;
: 486-490, 2019.
Article
in Korean
| WPRIM
| ID: wpr-738626
ABSTRACT
PURPOSE:
To report a case of bilateral posterior subcapsular cataract after taking oxcarbazepine (Trileptal®, Novartis, Basel, Swiss). CASESUMMARY:
A 19-year-old female visited our clinic with decreased vision in both eyes. Her best-corrected visual acuity was 0.3 in the right eye and 0.5 in the left eye, and slit-lamp examination revealed a bilateral cortical opacity and subcapsular cataract. She had been taking oxcarbazepine for epilepsy for 10 years, which was discontinued 3 years ago. Her mother had undergone cataract surgeries when she was approximately 46 years of age. No other risk factors for cataract were present.CONCLUSIONS:
In the present case, bilateral cortical opacity and subcapsular cataract were assumed to be associated with the use of oxcarbazepine. We suggest that oxcarbazepine could induce a cataract and recommend a regular follow-up by a qualified ophthalmologist.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Cataract
/
Visual Acuity
/
Risk Factors
/
Follow-Up Studies
/
Epilepsy
/
Mothers
Type of study:
Etiology study
/
Observational study
/
Prognostic study
/
Risk factors
Limits:
Female
/
Humans
Language:
Korean
Journal:
Journal of the Korean Ophthalmological Society
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS